Femasys Reports Q3 Sales of $405,000 and Net Loss of $4.6 Million

Femasys reported third-quarter 2026 sales of $404,597, down 44.5% year over year, and a net loss of $4.6 million. U.S. sales increased slightly to $347,039. The company said a $30 million private placement closed in August will support its U.S. commercial expansion and FemBloc pivotal trial.Financi…